← the journal·2026-08-14

Why we built ReachPill

Every startup we know has the same ritual. A launch is coming. Someone opens a doc titled "Launch — social plan". Someone else screenshots the brand guide into a thread. The designer gets pinged for "a quick banner, three sizes". The founder rewrites the tweet at 11pm because it "doesn't sound like us".

The launch goes fine. The next four weeks don't — because everything that made launch week work was hand-cranked, and nobody can hand-crank forever.

The diagnosis

Marketing teams don't have a creativity problem. They have a throughput problem wearing a creativity costume. The ideas exist. What's missing is the machine that turns one idea into nine platform-shaped, brand-correct artifacts — this week, and next week, and the week after.

The tools you'd reach for don't fix it:

  • Schedulers move finished content around the calendar. They don't make any.
  • Design tools make beautiful one-offs. Every one still costs a person-hour.
  • AI writers produce words that sound like everyone else's AI writer, because they know nothing about your brand beyond the prompt you pasted.

The treatment

ReachPill starts from a different premise: your brand should be infrastructure, not a PDF.

You teach it once — voice, palette, logo, mascot, the facts that must be true, the things you never say. That's your Brand DNA, and every single asset the system produces inherits it: campaign posts, blog heroes, captions, even where your logo lands on an image (composited deterministically — never drawn by a model, never mangled).

On top of that DNA sit campaigns that run themselves: describe a goal, get a narrative arc and a cadence, and the calendar fills — written, illustrated, and queued. Nothing ships without a human tap; the tap just moved to where your team already lives, including Slack.

Written by the machine, eventually

One more thing about this post: it lives in a plain markdown file in the website's repo, in exactly the format ReachPill commits when it publishes long-form content. The blog you're reading was built to be written by the product itself — the same pipeline that ships our customers' articles will ship ours.

That's the whole idea, really. The treatment works — so we're taking it too.